highperformr logo

Morningside Group's Overview

Total employees23
HeadquartersCambridge
Founded2020

Morningside Group is a private investment group founded in 1986 by the Chan family of Hong Kong. It is primarily engaged in private equity and venture capital investments. The group is known for its long-term investment approach and has a significant focus on life sciences, healthcare, technology, and other high-growth sectors globally. Morningside often invests in early-stage companies and supports them through various stages of development, leveraging its deep industry expertise and global network. They are recognized for backing innovative entrepreneurs and transformative technologies.

Where is Morningside Group's Headquarters?

HQ Function

Serves as a primary hub for North American venture capital and private equity investments, particularly in the biotech, pharmaceutical, and technology sectors. It's a center for deal sourcing, due diligence, and portfolio company support in the region.

Notable Features:

Located in the Kendall Square area, a globally recognized nexus for biotechnology and pharmaceutical innovation, surrounded by leading universities (like MIT), research institutions, and numerous life science companies.

Work Culture:

Characterized by an intellectually rigorous, entrepreneurial, and collaborative environment. The culture likely emphasizes deep scientific and market analysis, long-term vision, and active partnership with portfolio companies.

HQ Significance:

Its location in Cambridge places Morningside at the heart of the US East Coast's biotech and innovation ecosystem, facilitating access to cutting-edge research, talent, and investment opportunities.

Values Reflected in HQ: Innovation, strategic investment, proximity to cutting-edge research, and a commitment to fostering growth in high-potential sectors.

Location:

Morningside Group supports its global investment activities through strategically located offices in major innovation and financial centers, including North America (e.g., Cambridge/Boston) and Asia (e.g., Hong Kong, Shanghai). This presence enables them to source diverse investment opportunities, conduct thorough due diligence with local insights, provide hands-on support to their portfolio companies worldwide, and engage with various innovation ecosystems.

Street Address:

One Main Street, Suite 1250

City:

Cambridge

State/Province:

MA

Country:

USA

Morningside Group's Global Presence

Hong Kong, China

Address: Level 33, Man Yee Building, 68 Des Voeux Road Central, Central, Hong Kong

Coordinates investment strategies in Asia-Pacific, leverages local market knowledge, and manages relationships with regional partners and portfolio companies.

Shanghai, China

Address: 8 Corporate Avenue, 222 Hubin Road, Huangpu District, Shanghai, China

To identify and capitalize on growth opportunities within China's rapidly evolving economy and support local entrepreneurs.

Newton, MA, USA

Address: 2 Liberty Square, 11th Floor, Boston, MA 02109, USA (Note: Address for Morningside Technology Advisory, related entity)

Supports North American investment activities, potentially with a focus on different technology verticals or advisory functions.

Buying Intent Signals for Morningside Group

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Morningside Group

As of April 2025, Morningside Group' leadership includes:

Dr. Gerald Chan - Co-founder
Ronnie Chan - Co-founder / Chairman of Hang Lung Group (Family related)
Stephen Bruso - Managing Director, Morningside Ventures
Jason Ding - Managing Director, Morningside Ventures
Reenie McCarthy - CEO of Stealth BioTherapeutics (a Morningside affiliated company, key figure in their life science strategy)

Investors of Morningside Group

Morningside Group has been backed by several prominent investors over the years, including:

Morningside Group is a private investment firm that primarily invests proprietary capital derived from its founding family.
It does not typically raise funds from external Limited Partners (LPs) in the manner of traditional venture capital or private equity funds.
Their funding model allows for a long-term investment horizon without pressures from typical fund cycles.

Executive New Hires/Exits in the Last 12 Months

Hire0
Exits0

Specific executive movements within private investment firms like Morningside Group are not always widely publicized unless they involve very senior roles or public announcements related to new fund establishments or significant portfolio company involvement. Public information on hires/exits for the core investment team is limited for the past 12 months.

Technology (Tech Stack) used by Morningside Group

Discover the tools Morningside Group uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Morningside Group Email Formats and Examples

Morningside Group likely uses common corporate email formats. Based on industry standards and common patterns for investment firms, the most probable formats would involve combinations of first name, last name, and initials.

flast@morningside.com (e.g., jdoe@morningside.com) or first.last@morningside.com

Format

jdoe@morningside.com

Example

80%

Success rate

News and media

PR NewswireMarch 7, 2024

Morningside Group backed Adlai Nortye Biopharma Announces Pricing of Initial Public Offering

Adlai Nortye Biopharma Co., Ltd., a clinical-stage biopharmaceutical company focused on the development of innovative cancer therapies, in which Morningside Group is a significant pre-IPO shareholder, announced the pricing of its initial public offering. This highlights Morningside's role in funding and supporting biotech companies through to public markets....more

BioSpaceFebruary 26, 2024

Morningside Group affiliated Apollomics Inc. Reports Full Year 2023 Financial Results

Apollomics Inc., an innovative biopharmaceutical company committed to the discovery and development of mono- and combination- oncology therapies, where Morningside is a key investor, reported its financial results. This demonstrates ongoing involvement and oversight in its portfolio companies....more

GlobeNewswireJuly 13, 2023

Morningside Group participates in $33 Million Series A for Rona Therapeutics

Rona Therapeutics, a biotech company dedicated to pioneering the next generation of RNA medicines, announced the successful completion of a $33 million Series A financing. The round included new investors like Morningside Ventures, aimed at advancing its platform and pipeline....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Morningside Group, are just a search away.